Literature DB >> 22492832

Body mass index and colon cancer screening: a systematic review and meta-analysis.

Nisa M Maruthur1, Shari Bolen, Kimberly Gudzune, Frederick L Brancati, Jeanne M Clark.   

Abstract

BACKGROUND: Obesity is associated with increased colon cancer mortality and lower rates of mammography and Pap testing.
METHODS: We conducted a systematic review to determine whether obesity is associated with lower rates of colon cancer screening. We searched the PubMed, CINAHL, and Cochrane Library databases. Two investigators reviewed citations, abstracts, and articles independently. Two investigators abstracted study information sequentially and evaluated quality independently using standardized forms. We included all studies in our qualitative syntheses. We used random effects meta-analyses to combine those studies providing screening results by the following body mass index (BMI) categories: Normal, 18.5-24.9 kg/m(2) (reference); overweight, 25-29.9 kg/m(2); class I obesity, 30-34.9 kg/m(2); class II obesity, 35-39.9 kg/m(2); and class III obesity, ≥ 40 kg/m(2).
RESULTS: Of 5,543 citations, we included 23 articles. Almost all studies were cross-sectional and ascertained BMI and screening through self-report. BMI was not associated with colon cancer screening overall. The subgroup of obese white women reported lower rates of colon cancer screening compared with those with a normal BMI with combined ORs (95% CI) of 0.87 (0.82-0.93), 0.80 (0.65-0.99), and 0.73 (0.58-0.94) for class I, II, and III obesity, respectively. Results were similar among white men with class II obesity.
CONCLUSIONS: Overall, BMI was not associated with colon cancer screening. Obese white men and women may be less likely to undergo colon cancer screening compared with those with a normal BMI. IMPACT: Further investigation of this disparity may reduce the risk of obesity-related colon cancer death.

Entities:  

Mesh:

Year:  2012        PMID: 22492832      PMCID: PMC3930882          DOI: 10.1158/1055-9965.EPI-11-0826

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  53 in total

1.  Multiple behavioral risk factors for colorectal cancer and colorectal cancer screening status.

Authors:  Elliot J Coups; Sharon L Manne; Neal J Meropol; David S Weinberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

2.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Ann Intern Med       Date:  2007-10-16       Impact factor: 25.391

Review 3.  Accuracy of self-reported cancer-screening histories: a meta-analysis.

Authors:  Garth H Rauscher; Timothy P Johnson; Young Ik Cho; Jennifer A Walk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04-01       Impact factor: 4.254

Review 4.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.

Authors:  Andrew G Renehan; Margaret Tyson; Matthias Egger; Richard F Heller; Marcel Zwahlen
Journal:  Lancet       Date:  2008-02-16       Impact factor: 79.321

5.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

6.  Association of insurance with cancer care utilization and outcomes.

Authors:  Elizabeth Ward; Michael Halpern; Nicole Schrag; Vilma Cokkinides; Carol DeSantis; Priti Bandi; Rebecca Siegel; Andrew Stewart; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2007-12-20       Impact factor: 508.702

7.  Demographic, behavioral, psychosocial, and dietary correlates of cancer screening in African Americans.

Authors:  Jessie A Satia; Joseph A Galanko
Journal:  J Health Care Poor Underserved       Date:  2007-11

Review 8.  Obesity and screening for breast, cervical, and colorectal cancer in women: a review.

Authors:  Sarah S Cohen; Rachel T Palmieri; Sarah J Nyante; Daniel O Koralek; Sangmi Kim; Patrick Bradshaw; Andrew F Olshan
Journal:  Cancer       Date:  2008-05-01       Impact factor: 6.860

9.  Multiple health behaviors among overweight, class I obese, and class II obese persons.

Authors:  Aimee S James; Lucia Leone; Mira L Katz; Lorna Haughton McNeill; Marci K Campbell
Journal:  Ethn Dis       Date:  2008       Impact factor: 1.847

10.  Objective risk, subjective risk, and colorectal cancer screening among a clinic sample.

Authors:  B Alex Matthews; Ann B Nattinger; Thangam Venkatesan; Reza Shaker; Ruric C Anderson
Journal:  Psychol Health Med       Date:  2007-03       Impact factor: 2.423

View more
  19 in total

Review 1.  Do recent epidemiologic observations impact who and how we should screen for CRC?

Authors:  Ethan Bortniker; Joseph C Anderson
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

2.  Metabolic syndrome and gastrointestinal cancers.

Authors:  Jonathan Wei Jie Lee; Calvin Jianyi Koh; Khek Yu Ho
Journal:  Indian J Gastroenterol       Date:  2019-02

3.  Patterns of colorectal cancer screening uptake in newly eligible men and women.

Authors:  Karen J Wernli; Rebecca A Hubbard; Eric Johnson; Jessica Chubak; Aruna Kamineni; Beverly B Green; Carolyn M Rutter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-03       Impact factor: 4.254

4.  Are obese women more likely to participate in a mobile mammography program?

Authors:  Elvonna Atkins; Suresh Madhavan; Traci LeMasters; Ami Vyas; Sara Jane Gainor; Scot Remick
Journal:  J Community Health       Date:  2013-04

Review 5.  Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.

Authors:  Katherine Esposito; Paolo Chiodini; Annalisa Capuano; Giuseppe Bellastella; Maria Ida Maiorino; Concetta Rafaniello; Demosthenes B Panagiotakos; Dario Giugliano
Journal:  Endocrine       Date:  2013-04-02       Impact factor: 3.633

Review 6.  Clinical management of obese patients with cancer.

Authors:  Wenjing Tao; Jesper Lagergren
Journal:  Nat Rev Clin Oncol       Date:  2013-07-16       Impact factor: 66.675

7.  Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  Cari M Kitahara; Sonja I Berndt; Amy Berrington de González; Helen G Coleman; Robert E Schoen; Richard B Hayes; Wen-Yi Huang
Journal:  J Clin Oncol       Date:  2013-05-28       Impact factor: 44.544

8.  Colorectal cancer risk based on extended family history and body mass index.

Authors:  Heather M Ochs-Balcom; Priyanka Kanth; James M Farnham; Samir Abdelrahman; Lisa A Cannon-Albright
Journal:  Genet Epidemiol       Date:  2020-07-16       Impact factor: 2.135

9.  Risk of colonic cancer is not higher in the obese Lep(ob) mouse model compared to lean littermates.

Authors:  Angelos K Sikalidis; Mark D Fitch; Sharon E Fleming
Journal:  Pathol Oncol Res       Date:  2013-06-29       Impact factor: 3.201

Review 10.  The risk of colonic adenomas and colonic cancer in obesity.

Authors:  Adeyinka O Laiyemo
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-07-10       Impact factor: 3.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.